Skip to main navigation Skip to search Skip to main content

Dose Optimization of Pembrolizumab: Less May Be More

  • Mark J. Ratain*
  • , Cody J. Peer
  • , William D. Figg
  • , Daniel A. Goldstein
  • *Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

7 Scopus citations
Original languageEnglish
Pages (from-to)993
Number of pages1
JournalClinical Pharmacology and Therapeutics
Volume111
Issue number5
DOIs
StatePublished - May 2022

Fingerprint

Dive into the research topics of 'Dose Optimization of Pembrolizumab: Less May Be More'. Together they form a unique fingerprint.

Cite this